Clinical Trials in Padua, PD
12 recruiting
Showing 1–12 of 12 trials
Recruiting
Observational, Prospective, Multi-centric Study Exploring HER2 Mutations Incidence and Therapeutic Management in aNSCLC
HER2NSCLC (Advanced Non-small Cell Lung Cancer)
Gruppo Oncologico Italiano di Ricerca Clinica50 enrolled22 locationsNCT07356544
Recruiting
Phase 2
An Open-label Study of JSB462 (Luxdegalutamide) in Combination With Abiraterone in Adult Male Patients With Metastatic Hormone-sensitive Prostate Cancer (mHSPC)
Metastatic Hormone Sensitive Prostate Cancer
Novartis Pharmaceuticals150 enrolled57 locationsNCT06991556
Recruiting
stereOtactic Body RadIothErapy for exTracranial oligomeTastAtic Breast Cancer: Multi Institutional Retrospective Database
Breast CancerOligometastasis
Istituto Clinico Humanitas300 enrolled28 locationsNCT07397585
Recruiting
Phase 1Phase 2
5FU/LV, Irinotecan, Temozolomide and Bevacizumab for MGMT Silenced, Microsatellite Stable Metastatic Colorectal Cancer.
Metastatic Colorectal Cancer
Fondazione IRCCS Istituto Nazionale dei Tumori, Milano27 enrolled3 locationsNCT04689347
Recruiting
Observational Study on Endometrial Stromal Tumors
Endometrial Stromal Tumors
Italian Sarcoma Group100 enrolled13 locationsNCT02829437
Recruiting
Phase 3
FOLFOXIRI Plus Bevacizumab With or Without Atezolizumab as 1st Line Treatment of pMMR and IS IC-High Metastatic Colorectal Cancer Patients.
Colorectal, Cancer
Gruppo Oncologico del Nord-Ovest238 enrolled24 locationsNCT06733038
Recruiting
ALFAOMEGA Master Observational Trial
Colorectal, Cancer
IFOM ETS - The AIRC Institute of Molecular Oncology3,000 enrolled19 locationsNCT04120935
Recruiting
A Retrospective Protocol Empowering Precision Research in Colorectal Cancer (ALFAOMEGA-RETRÒ)
Colorectal, Cancer
IFOM ETS - The AIRC Institute of Molecular Oncology500 enrolled13 locationsNCT05101382
Recruiting
Measure of Outcomes in Patients With Advanced Ovarian Cancer According to Homologous Recombination Status and Matched Therapies in a Real-world Scenario
Ovarian Cancer
Consorzio Oncotech300 enrolled21 locationsNCT06836219
Recruiting
Atezolizumab-bevacizumab and Other Immunotherapies: Real-life Experience for Treatment of Hepatocellular Carcinoma
Hepatocellular Carcinoma (HCC)
IRCCS Azienda Ospedaliero-Universitaria di Bologna1,000 enrolled24 locationsNCT06806579
Recruiting
Phase 3
Letrozole for Estrogen/Progesterone Receptor Positive Low-grade Serous Epithelial Ovarian Cancer (LEPRE Trial)
Carcinoma, Ovarian EpithelialLow Grade Serous Adenocarcinoma of Ovary
Ente Ospedaliero Ospedali Galliera132 enrolled19 locationsNCT05601700
Recruiting
Phase 4
Akynzeo as Antiemetic Treatment in Patients With Endometrial Cancer
Endometrial Cancer
Fondazione IRCCS Istituto Nazionale dei Tumori, Milano84 enrolled8 locationsNCT06726291